---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-078354"
form_type: "8-K"
ticker: "MIST"
cik: "0001408443"
company_name: "Milestone Pharmaceuticals Inc."
filed_at: "2022-07-08T23:59:59+00:00"
generated_at: "2026-06-24T18:16:55.870673+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Milestone Pharmaceuticals shareholders elect directors, approve auditor and equity plan amendment at 2022 meeting

## Summary
- All six director nominees elected: Joseph Oliveto, Lisa M. Giles, Richard Pasternak, Debra K. Liebert, Michael Tomsicek, Robert J. Wills. Votes for each ranged 19,105,725 – 19,110,012.
- PricewaterhouseCoopers LLP appointed as auditor for 2023 with 24,809,612 votes for, 0 against, 217,072 withheld.
- Amendment to 2019 Equity Incentive Plan approved; increase of 1,000,000 shares authorized. 15,462,071 for, 3,652,167 against, 5,912,446 broker non-votes.

## SEC filing metadata
- accession: 0001104659-22-078354
- form_type: 8-K
- ticker: MIST
- cik: 0001408443
- company_name: Milestone Pharmaceuticals Inc.
- filed_at: 2022-07-08T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/0001104659-22-078354-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1408443/000110465922078354/tm2220674d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-078354
- JSON: https://secwatch.observer/filing/0001104659-22-078354.json
- Plain text: https://secwatch.observer/filing/0001104659-22-078354.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.